Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
August 16, 2024
Tags
Business News
Crime
Business
From
CNBC.com News
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
August 16, 2024
Tags
Pharmaceuticals
Bavarian Nordic A/S
Health care industry
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Biotechnology
Social issues
Companies
From
CNBC.com News
Health stocks jump as WHO declares mpox global health emergency
August 15, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Bavarian Nordic A/S
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Amgen Inc
Bristol/Myers Squibb Co
Merck & Co Inc
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health care industry
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Breaking news
Business
Pharmaceuticals
From
CNBC.com News
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
August 07, 2024
Tags
Earnings
CVS Health Corp
Health care industry
From
CNBC.com News
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
August 07, 2024
Tags
Health care industry
Pharmaceuticals
Europe Markets
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Health & Science
Breaking News: Politics
Healthy Returns
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Your health records are coming to new apps. Here's why
August 01, 2024
Tags
Breaking News: Business
Breaking News: Technology
Health & Science
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Biotech and Pharmaceuticals
Earnings
Health care industry
From
CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
23andMe CEO files proposal to take company private as stock craters
July 31, 2024
Tags
Technology
Mobile
Enterprise
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Eli Lilly and Co
Viking Therapeutics Inc
Science
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Eisai Co Ltd
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Neuralink rival Synchron lets patients control Apple Vision Pro with their thoughts
July 30, 2024
Tags
Entertainment
Media
Tech Guide
From
CNBC.com News
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
July 30, 2024
Tags
Health care industry
Earnings
Pfizer Inc
From
CNBC.com News
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
July 30, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Dexcom shares plunge more than 40%, head for worst day on record
July 26, 2024
Tags
Breaking News: Technology
Health & Science
US: News
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Eisai Co Ltd
Eli Lilly and Co
Health care industry
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
Biotech and Pharmaceuticals
Bristol/Myers Squibb Co
Health care industry
From
CNBC.com News
Dexcom shares plummet more than 30% after company lowers fiscal year guidance
July 25, 2024
Tags
Dexcom Inc
Breaking News: Technology
Health & Science
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Health care industry
Viking Therapeutics Inc
Eli Lilly and Co
From
CNBC.com News
GE HealthCare taps Amazon Web Services to build generative AI for medical use
July 25, 2024
Tags
Amazon/com Inc
Technology
Mobile
From
CNBC.com News
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know
July 25, 2024
Tags
Asia Politics
Health care industry
Asia News
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.